Clinical Trials
5 trialsNCT00227513 2014-02-24
Vorinostat and Bortezomib in Treating Patients With Metastatic or Unresectable Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00324480 2014-02-24
Vorinostat and Alvocidib in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00243100 2013-12-16
Vorinostat and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00331955 2013-07-02
Vorinostat and Doxorubicin in Treating Patients With Metastatic or Locally Advanced Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00287937 2013-02-07
Vorinostat, Paclitaxel, and Carboplatin in Treating Patients With Advanced or Refractory Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed